EASTERN COOPERATIVE ONCOLOGY GROUP

东方肿瘤合作组

• 批准号: 6172157
• 负责人: thomas matthew habermann
• 金额: $ 21.25万
• 依托单位: MAYO CLINIC ROCHESTER
• 依托单位国家: 美国
• 财政年份: 1978
• 资助国家: 美国
• 起止时间: 1978-06-01 至 2004-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6172157
• 关键词: AIDS; antineoplastics; biological response modifiers; bone marrow transplantation; brain neoplasms; breast neoplasms; cancer prevention; clinical research; clinical trials; combination cancer therapy; combination chemotherapy; cooperative study; fluorescent in situ hybridization; gastrointestinal neoplasms; gene therapy; head /neck neoplasm; health behavior; human subject; human therapy evaluation; leukemia; lymphoma; melanoma; minimal residual disease; multiple myeloma; neoplasm /cancer chemotherapy; neoplasm /cancer genetics; neoplasm /cancer immunotherapy; neoplasm /cancer pharmacology; neoplasm /cancer radiation therapy; neoplasm /cancer surgery; neoplasm /cancer vaccine; nucleic acid sequence; pathology; prognosis; reproductive system neoplasm; thorax neoplasm; tissue resource /registry; urinary tract neoplasms

The purpose of this grant application is to support Mayo Clinic membership in the Eastern Cooperative Oncology Group (ECOG). The goals are directed toward a greater understanding of cancer, a better understanding of cancer-related problems, development of improved cancer treatment programs, and improved cancer-patient survival. Mayo Clinic has the resources, personnel, facilities, a patient population to facilitate strong contributions to the research programs of the Eastern Cooperative Oncology Group. With the continued growth and development of the Mayo medical practice, we would anticipate significant protocol entry and scientific contribution. The ECOG affiliation and treatment program which have evolved provide major benefits to Mayo Clinic, its investigators, regional cancer programs, and the large group of cancer patients who are involved in these research activities. The specific aims of this grant proposal are to support the following aspects of Mayo Clinic ECOG research activities including: 1. Patient accrual to group-wide ECOG cancer treatment protocols. 2. The evaluation of new protocol design and treatment regimens to provide group-wide ECOG Phase II and II cancer treatment protocols. 3. Coordination of, and participation in, adjunctive laboratory-based correlative studies in association with ECOG cancer treatment protocols. 4. Participation in disease-specific activities and such administrative roles as might be appointed and appropriate.

这项赠款申请的目的是支持梅奥诊所成为东部合作肿瘤学小组(ECOG)的成员。这些目标旨在更好地了解癌症，更好地了解与癌症相关的问题，开发改进的癌症治疗计划，并提高癌症患者的存活率。梅奥诊所拥有资源、人员、设施、患者群体，为东方合作肿瘤学小组的研究计划做出了强有力的贡献。随着梅奥医疗实践的持续增长和发展，我们预计会有重大的议定书条目和科学贡献。已经发展起来的ECOG从属关系和治疗计划为梅奥诊所、其研究人员、地区性癌症计划以及参与这些研究活动的广大癌症患者提供了重大好处。这项赠款提案的具体目的是支持梅奥诊所ECOG研究活动的以下方面：1.患者对集团范围的ECOG癌症治疗方案的应计费用。2.评价新的方案设计和治疗方案，以提供全组ECOG第二阶段和第二阶段癌症治疗方案。3.协调和参与与经社理事会癌症治疗方案有关的以实验室为基础的附属相关研究。4.参与针对疾病的活动以及可能被任命和适当的行政职责。